1046793-78-5 Usage
Description
1H-Pyrrolo[2,3-b]pyridine, 5-bromo-3-(2-methyl-4-thiazolyl)is a heterocyclic chemical compound with the molecular formula C13H9BrN4S. It features a pyrido[2,3-b]pyrrole core structure, a bromine substituent at the 5-position, and a 2-methyl-4-thiazolyl group attached at the 3-position. 1H-Pyrrolo[2,3-b]pyridine, 5-broMo-3-(2-Methyl-4-thiazolyl)holds potential in various fields, including organic synthesis, pharmaceuticals, and material science, and is a subject of interest for future research and development.
Uses
Used in Organic Synthesis:
1H-Pyrrolo[2,3-b]pyridine, 5-bromo-3-(2-methyl-4-thiazolyl)is used as a synthetic intermediate for the creation of various organic compounds. Its unique structure allows for the development of new molecules with potential applications in different industries.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 1H-Pyrrolo[2,3-b]pyridine, 5-bromo-3-(2-methyl-4-thiazolyl)is used as a potential lead compound for the development of new drugs. Its heterocyclic nature and functional groups may contribute to the discovery of novel therapeutic agents.
Used in Material Science:
1H-Pyrrolo[2,3-b]pyridine, 5-bromo-3-(2-methyl-4-thiazolyl)is also utilized in material science for the design and synthesis of new materials with specific properties. Its structural features can be leveraged to create materials with applications in various fields, such as electronics or nanotechnology.
Check Digit Verification of cas no
The CAS Registry Mumber 1046793-78-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,4,6,7,9 and 3 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1046793-78:
(9*1)+(8*0)+(7*4)+(6*6)+(5*7)+(4*9)+(3*3)+(2*7)+(1*8)=175
175 % 10 = 5
So 1046793-78-5 is a valid CAS Registry Number.
1046793-78-5Relevant articles and documents
THE USE OF 7-AZAINDOLES IN THE INHIBITION OF C-JUN N-TERMINAL KINASE
-
Page/Page column 195, (2008/12/08)
The present invention provides a compound of formula (I); or a pharmaceutically acceptable salt thereof in the inhibition of c-Jun N-terminal kinase (JNK) activity and particularly in the treatment of neurodegenerative disorders, inflammatory diseases and
